In a video appearing on P&T Community, Dr. Robert Andtbacka of the University of Utah discusses plans for a phase 3 trial involving PV-10 in patients with stage 3b and 3c melanoma who have failed or were not candidates for immunotherapy and patients who are BRAF-negative and who currently don't have good treatment options.

The video may be viewed from the P&T Community website at the following link:

Plans for a Phase 3 Study of PV-10 in Melanoma

* Video clips appear courtesy of www.ptcommunity.com (MediMedia USA, Inc., publishers) *

distributed by